Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
GRL-142
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | GRL-142 is a potent HIV-1 protease inhibitor capable of crossing the blood-brain barrier. It exhibits exceptional inhibitory activity against both wild-type and multi-drug resistant strains (IC50=0.0094 nM). GRL-142 employs a unique scaffold-binding mechanism, synergistically engaging with the P2/P2' segments through fluorine-mediated stable interactions to maintain its bioactive conformation. It adapts to p51HIV-1 protease mutants by directly interacting with flap-tip residues to maintain flap-closed states. Furthermore, GRL-142 disrupts the flap-water hydrogen bond network in wild-type protease, effectively blocking viral replication. This compound is applicable to studies of HIV-1 infection and associated neurocognitive disorders (HAND). |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.